US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 0.500
  • -0.009-1.77%
Trading Nov 25 09:31 ET
21.37MMarket Cap-245P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.33M
214.00K
-1.11M
Miss Est.
+289.33%
-37.24%
-83.88%
EPS
-0.55
-0.32
+0.23
Beat Est.
+68.24%
+81.40%
+41.42%
Analyst Rating
Buy

Nov 25, 2024

BioXcel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 413.840K --
Nov 14, 2024 2024/Q3 214.000K / 1.328M --
Aug 6, 2024 2024/Q2 1.104M / 1.100M --
May 9, 2024 2024/Q1 582.000K / 632.600K --
Mar 12, 2024 2023/Q4 376.000K / 741.290K --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 413.840K--
Nov 14, 20242024/Q3214.000K / 1.328M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--

Unlock Free Earnings Estimates

BioXcel Therapeutics Earnings Reports

  • BioXcel Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 22:17

  • BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 14 20:07

  • BioXcel Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 21:08

  • BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 6 19:08

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 25, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data